A61P 5 - Drugs for disorders of the endocrine system

Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2002
11/28/2002	US20020177213 Tissue plasminogen activator-like protease
11/28/2002	US20020176818 Radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid
11/28/2002	DE10123958A1 Identifying ligands for G protein-coupled receptors, useful for treating cardiovascular disease, by using calcium-sensitive fluorophores in cells expressing G alpha proteins
11/28/2002	CA2450535A1 Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists
11/28/2002	CA2449442A1 Combination medicament for treatment of neoplastic diseases
11/28/2002	CA2448022A1 Compositions for protein delivery via the pulmonary route
11/28/2002	CA2447340A1 Kinases and phosphatases
11/28/2002	CA2447103A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002	CA2447023A1 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/28/2002	CA2446734A1 Antibodies against tumor necrosis factor delta (april)
11/28/2002	CA2444955A1 Inactivation of genes of the mep pathway
11/28/2002	CA2444787A1 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen
11/27/2002	EP1260519A1 Membrane receptors for steroids and sterols
11/27/2002	EP1260228A2 Human growth gene and short stature gene region. Therapeutic uses
11/27/2002	EP1260225A1 A pharmaceutical composition for use in hormone replacement therapy
11/27/2002	EP1259520A2 Novel purines
11/27/2002	EP1259504A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents
11/27/2002	EP1259494A1 Aryloxyacetic acids for diabetes and lipid disorders
11/27/2002	EP1259487A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors
11/27/2002	EP1259262A1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
11/27/2002	EP1259246A2 Use of dpp-iv inhibitors for the treatment of diabetes
11/27/2002	EP1259223A1 Protein matrix materials, devices and methods of making and using thereof
11/27/2002	EP1017672B1 New npy antagonists
11/27/2002	EP0857064B1 Stabilised pharmaceutical preparations containing thyroid hormone
11/27/2002	CN1382151A Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl)-1h-indol-5-ols
11/27/2002	CN1382124A Bicycle androgen and progesterone receptor modulator compounds and methods
11/27/2002	CN1382118A Biocyclic amino acids aspharmaceutical agents
11/27/2002	CN1382054A Novel contraceptive medicament and method for producing the same
11/27/2002	CN1382053A Novel hormonal composition and use thereof
11/27/2002	CN1382050A Oral formulations for anti-tumor compounds
11/27/2002	CN1382036A Solubilized pharmaceutical composition for parenteral administration
11/26/2002	US6486186 Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the same
11/26/2002	US6485706 Dehydration product of insulin and an orally effective nonsteroidal membrane-permeation enhancer, for administration to buccal mucosa via spraying suspension of solid particles
11/21/2002	WO2002092831A2 Method for identifying ligands for g protein coupled receptors
11/21/2002	WO2002092808A1 Random gene unidirectional antisense library
11/21/2002	WO2002092807A1 Unigene unidirectional antisense library
11/21/2002	WO2002092759A2 Molecules for disease detection and treatment
11/21/2002	WO2002092618A1 17 alpha-hydroxy-4-androstene-3-one and the 14, 15-methylene-derivatives thereof
11/21/2002	WO2002092597A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.0?2,11.04.9¿)-hexadeca-2.(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002	WO2002092571A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002	WO2002092565A2 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists
11/21/2002	WO2002092558A1 Polythiourea lipid derivatives
11/21/2002	WO2002092550A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/21/2002	WO2002092129A2 Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist
11/21/2002	WO2002092089A1 Tartrate salts of 5,8,14-triazatetracyclo {10.3.1.0?2,11.04,9¿}-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002	WO2002092064A2 Therapeutic method for inducing tolerance
11/21/2002	WO2002092016A2 Therapeutic use of rank antagonists
11/21/2002	WO2002092013A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002	WO2002092011A2 Methods of treating antibody-mediated pathologies using agents which inhibit cd21
11/21/2002	WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
11/21/2002	WO2002091993A2 Estrogen receptor modulators
11/21/2002	WO2002074322A3 Human growth hormone for treating children with abnormal short stature and kits and methods for diagnosing gs protein dysfunctions
11/21/2002	WO2002072084A3 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity
11/21/2002	WO2002072034A3 Chronotherapeutic dosage forms
11/21/2002	WO2002055514A3 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators
11/21/2002	WO2002049629A8 Methods for reducing chronic stress in mammals
11/21/2002	WO2002011705A3 Composition for combined use of aromatase inhibitors
11/21/2002	WO2001019397A9 Methods and compositions utilizing rad51
11/21/2002	US20020173669 Steroid hormone products and methods for preparing them
11/21/2002	US20020173645 Acylating a 2-aryl-6-alkoxy-benzo(b)thiophene with a p-(tertiaryaminoethoxy)benzoic acid hydrohalide salt or the corresponding benzoyl halide in presence of a boron trihalide
11/21/2002	US20020173586 Thermogelling biodegradable aqueous polymer solution
11/21/2002	US20020173540 Using plant extract
11/21/2002	US20020173531 Central nervous system disorders; psychological disorders
11/21/2002	US20020173510 Nutrient mixture; fatty acid, calcium compound and vitamins
11/21/2002	US20020173499 Estrogen replacement therapy
11/21/2002	US20020173445 Selective androgen receptor modulators and methods for their identification, design and use
11/21/2002	CA2460603A1 Unigene unidirectional antisense library
11/21/2002	CA2447576A1 Use of hmg fragment as anti-inflammatory agents
11/21/2002	CA2447518A1 Therapeutic use of rank antagonists
11/21/2002	CA2447286A1 Random gene unidirectional antisense library
11/21/2002	CA2447116A1 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002	CA2446988A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.02,11.04.9)-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002	CA2446953A1 Methods of treating antibody-mediated pathologies using agents which inhibit cd21
11/21/2002	CA2446747A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/21/2002	CA2446717A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002	CA2445922A1 Estrogen receptor modulators
11/21/2002	CA2445366A1 Molecules for disease detection and treatment
11/20/2002	EP1258727A1 Methods of screening for anti-androgen agents
11/20/2002	EP1258474A2 Alkylamide compounds
11/20/2002	EP1258245A2 Accelerated release composition containing bromocriptine
11/20/2002	EP1257646A2 Transporters and ion channels
11/20/2002	EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using
11/20/2002	EP1257555A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
11/20/2002	EP1257526A1 Aniline-derived ligands for the thyroid receptor
11/20/2002	EP1257304A1 Foam-forming wound dressing
11/20/2002	EP1257280A1 Drospirenone for hormone replacement therapy
11/20/2002	EP1163259B1 14.beta.,17-alpha-hydroxymethylandrostane derivatives as androgens
11/20/2002	EP0879050B1 Captopril tablets
11/19/2002	US6482825 Growth-hormone secretagogues
11/19/2002	US6482812 Method of locking 1α-OH of vitamin D compounds in axial orientation
11/19/2002	US6482517 Coated particles, methods of making and using
11/19/2002	US6481435 Closure-cap and container as a two-chamber cartridge for nebulizers for producing aerosols and active substance formulations, suitable for storage
11/19/2002	CA2272990C Heptapeptide oxytocin analogues
11/19/2002	CA2236422C Hydrolysis-optimized lipid emulsions and use thereof
11/18/2002	WO2001087878A1 Novel benzothiophene derivatives
11/18/2002	CA2409821A1 Novel benzothiophene derivatives
11/15/2002	WO2001090053A1 Diphenylmethane derivatives
11/15/2002	WO2001087875A1 Novel benzofuran derivatives
11/15/2002	CA2409144A1 Diphenylmethane derivatives
11/15/2002	CA2409096A1 Novel benzofuran derivatives

1 ... 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 ... 290